Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1981 Nov 28;283(6304):1429–1432. doi: 10.1136/bmj.283.6304.1429

Clinical value of serum immunoreactive trypsin concentration.

W S Ruddell, C J Mitchell, I Hamilton, J P Leek, J Kelleher
PMCID: PMC1507645  PMID: 6797570

Abstract

The clinical value of estimation of serum concentrations of immunoreactive trypsin was evaluated by studying 46 healthy controls, 23 controls in hospital, 44 patients with chronic pancreatic disease, and 184 patients with non-pancreatic conditions in which pancreatic disease commonly enters into the differential diagnosis. Serum trypsin concentration had a log normal distribution in the controls, and the calculated normal range was considerably wider than that previously reported. The concentration was abnormal in only 13 out of 27 patients with chronic pancreatitis and was extremely variable in patients with pancreatic cancer. Abnormal results occurred in 11% of the patients with non-pancreatic disease. Eighteen patients had a subnormal trypsin concentration, of whom six did not have pancreatic disease and 12 had either chronic pancreatitis or pancreatic cancer. There was no correlation between serum trypsin concentration and mean tryptic activity as measured by the Lundh test. Of 11 patients with pancreatic steatorrhoea, only seven had subnormal trypsin concentrations. There results suggest that the serum concentrations of immunoreactive trypsin has a low specificity and sensitivity for pancreatic disease and does no reflect the degree exocrine insufficiency in patients with proved chronic pancreatitis.

Full text

PDF
1429

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adrian T. E., Besterman H. S., Mallinson C. N., Pera A., Redshaw M. R., Wood T. P., Bloom S. R. Plasma trypsin in chronic pancreatitis and pancreatic adenocarcinoma. Clin Chim Acta. 1979 Oct 1;97(2-3):205–212. doi: 10.1016/0009-8981(79)90417-0. [DOI] [PubMed] [Google Scholar]
  2. Cook H. B., Lennard-Jones J. E., Sherif S. M., Wiggins H. S. Measurement of tryptic activity in intestinal juice as a diagnostic test of pancreatic disease. Gut. 1967 Aug;8(4):408–414. doi: 10.1136/gut.8.4.408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Elias E., Redshaw M., Wood T. Diagnostic importance of changes in circulating concentrations of immunoreactive trypsin. Lancet. 1977 Jul 9;2(8028):66–68. doi: 10.1016/s0140-6736(77)90066-6. [DOI] [PubMed] [Google Scholar]
  4. Gamble D. R., Moffatt A., Marks V. Serum immunoreactive trypsin concentrations in infectious and non-infectious illnesses and in juvenile diabetes. J Clin Pathol. 1979 Sep;32(9):897–901. doi: 10.1136/jcp.32.9.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kalser M. H., Leite C. A., Warren W. D. Fat assimilation after massive distal pancreatectomy. N Engl J Med. 1968 Sep 12;279(11):570–576. doi: 10.1056/NEJM196809122791103. [DOI] [PubMed] [Google Scholar]
  6. Koop H., Lankisch P. G., Stöckmann F., Arnold R. Trypsin radioimmunoassay in the diagnosis of chronic pancreatitis. Digestion. 1980;20(3):151–156. doi: 10.1159/000198434. [DOI] [PubMed] [Google Scholar]
  7. Lake-Bakaar G., McKavanagh S., Gatus B., Summerfield J. A. The relative values of serum immuno-reactive trypsin concentration and total amylase activity in the diagnosis of mumps, chronic renal failure, and pancreatic disease. Scand J Gastroenterol. 1980;15(1):97–101. doi: 10.3109/00365528009181438. [DOI] [PubMed] [Google Scholar]
  8. Lake-Bakaar G., McKavanagh S., Redshaw M., Wood T., Summerfield J. A., Elias E. Serum immunoreactive trypsin concentration after a Lundh meal. Its value in the diagnosis of pancreatic disease. J Clin Pathol. 1979 Oct;32(10):1003–1008. doi: 10.1136/jcp.32.10.1003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Malvano R., Marchisio M., Massaglia A., Giacosa P. A., Zannino M., Andriulli A., Burlina A. Radioimmunoassay of trypsin-like substance in human serum. Scand J Gastroenterol Suppl. 1980;62:3–10. [PubMed] [Google Scholar]
  10. Mitchell C. J., Humphrey C. S., Bullen A. W., Kelleher J., Losowsky M. S. Improved diagnostic accuracy of a modified oral pancreatic function test. Scand J Gastroenterol. 1979;14(6):737–741. doi: 10.3109/00365527909181946. [DOI] [PubMed] [Google Scholar]
  11. O'Donnell M. D., FitzGerald O., McGeeney K. F. Differential serum amylase determination by use of an inhibitor, and design of a routine procedure. Clin Chem. 1977 Mar;23(3):560–566. [PubMed] [Google Scholar]
  12. Temler R. S., Felber J. P. Radioimmunoassay of human plasma trypsin. Biochim Biophys Acta. 1976 Oct 11;445(3):720–728. doi: 10.1016/0005-2744(76)90122-4. [DOI] [PubMed] [Google Scholar]
  13. Wiggins H. S. Simple method for estimating trypsin. Gut. 1967 Aug;8(4):415–416. doi: 10.1136/gut.8.4.415. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES